Results 191 to 200 of about 755,158 (258)

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

CXCR4 antagonism corrects neutrophil abnormalities and reduces pneumonia severity in a pharmacological mouse model of CXCR2 loss-of-function-mediated neutropenia. [PDF]

open access: yesFront Immunol
Nguyen CH   +8 more
europepmc   +1 more source

Wearables for health monitoring: body composition estimates of commercial smartwatch and clinical bioelectrical impedance device. [PDF]

open access: yesFront Sports Act Living
Carrier B   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy